KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
Adjusted price
+91.77% total return, past year
Key statistics
- Market cap
- $8.9B
- P/E (TTM)
- —
- 52-week range
- $55.80$127.31
- Beta (5Y monthly)
- 1.97
- Median dollar volume
- $80M
- Shares outstanding
- 83.2M
- Revenue, last 12 months
- $105M
- Sector
- Health Care
- First close
- Aug 21, 2020
Returns
Total
- 1M
- −9.5%
- YTD
- +38.0%
- 1Y
- +91.8%
Per year
- 3Y
- +99.3%
- 5Y
- +12.3%
- Since 2020
- +21.1%
Financials
Annual returns
2020 from Aug 21 · 2026 through Oct 2